Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-cyclodextrin is a cyclic oligosaccharide composed of six glucose units linked by alpha-1,4-glycosidic bonds, forming a torus-shaped structure with a hydrophobic internal cavity and a hydrophilic exterior. It is naturally produced from starch via enzymatic conversion by cyclodextrin glycosyltransferase and is widely utilized in the pharmaceutical, food, and cosmetic industries. In medicine, it primarily serves as a functional excipient to improve the aqueous solubility, stability, and bioavailability of hydrophobic drugs through the formation of non-covalent host-guest inclusion complexes. Beyond its role as a carrier, alpha-cyclodextrin acts as a soluble dietary fiber that can physically sequester dietary lipids and cholesterol in the gastrointestinal tract, thereby reducing their absorption and lowering serum lipid levels. It also demonstrates the ability to modulate glycemic response by interfering with carbohydrate digestion, potentially through the competitive inhibition of enzymes such as alpha-amylase. While generally recognized as safe (GRAS) for oral consumption, its systemic use is constrained by potential nephrotoxicity and hemolytic activity at high concentrations.
Alpha-cyclodextrin acts primarily through the formation of non-covalent host-guest inclusion complexes, where its hydrophobic internal cavity encapsulates lipophilic molecules to enhance their solubility and stability. In the gastrointestinal tract, it functions as a sequestering agent for dietary fats and cholesterol and may inhibit digestive enzymes such as alpha-amylase to modulate carbohydrate absorption.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-cyclodextrin (α-CD).